Lancet Neurology, The, ISSN 1474-4422, 2011, Volume 10, Issue 6, pp. 509 - 519
Summary Background Human retinal pigment epithelial (RPE) cells produce levodopa and their transplantation into the striatum might improve continuity of...
Neurology | FETAL NIGRAL TRANSPLANTATION | TYROSINASE BIOSYNTHESIS | PHASE-I TRIAL | IMPLANTATION | NEUROTROPHIC FACTOR | TOLERABILITY | IMPROVEMENT | GENE-THERAPY | OPEN-LABEL | PROGRESSION | CLINICAL NEUROLOGY | Epithelial Cells - transplantation | Parkinson Disease - pathology | Epithelial Cells - metabolism | Double-Blind Method | Levodopa - therapeutic use | Humans | Middle Aged | Male | Treatment Outcome | Parkinson Disease - drug therapy | Parkinson Disease - physiopathology | Drug Carriers | Parkinson Disease - surgery | Placebos - therapeutic use | Adult | Female | Aged | Corpus Striatum - surgery | Epithelial Cells - cytology | Levodopa - metabolism | Retinal Pigment Epithelium - cytology
Neurology | FETAL NIGRAL TRANSPLANTATION | TYROSINASE BIOSYNTHESIS | PHASE-I TRIAL | IMPLANTATION | NEUROTROPHIC FACTOR | TOLERABILITY | IMPROVEMENT | GENE-THERAPY | OPEN-LABEL | PROGRESSION | CLINICAL NEUROLOGY | Epithelial Cells - transplantation | Parkinson Disease - pathology | Epithelial Cells - metabolism | Double-Blind Method | Levodopa - therapeutic use | Humans | Middle Aged | Male | Treatment Outcome | Parkinson Disease - drug therapy | Parkinson Disease - physiopathology | Drug Carriers | Parkinson Disease - surgery | Placebos - therapeutic use | Adult | Female | Aged | Corpus Striatum - surgery | Epithelial Cells - cytology | Levodopa - metabolism | Retinal Pigment Epithelium - cytology
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2002, Volume 347, Issue 5, pp. 322 - 329
The number of effective, long-term treatments for pulmonary hypertension is limited. In this double-blind, randomized trial, an aerosolized form of iloprost, a...
MEDICINE, GENERAL & INTERNAL | THERAPY | ANALOG | ARTERIAL-HYPERTENSION | AEROSOLIZED PROSTACYCLIN | NITRIC-OXIDE | DOUBLE-BLIND | EXERCISE CAPACITY | CONTINUOUS INTRAVENOUS EPOPROSTENOL | Hypertension, Pulmonary - classification | Iloprost - administration & dosage | Iloprost - adverse effects | Humans | Middle Aged | Administration, Inhalation | Hypertension, Pulmonary - physiopathology | Male | Dyspnea - etiology | Exercise Tolerance - drug effects | Walking | Dyspnea - drug therapy | Female | Hemodynamics - drug effects | Hypertension, Pulmonary - drug therapy | Vasodilator Agents - adverse effects | Vasodilator Agents - administration & dosage | Drug therapy | Pulmonary hypertension | Hypertension | Pulmonary arteries | Nitric oxide | Mortality | Hemophilia
MEDICINE, GENERAL & INTERNAL | THERAPY | ANALOG | ARTERIAL-HYPERTENSION | AEROSOLIZED PROSTACYCLIN | NITRIC-OXIDE | DOUBLE-BLIND | EXERCISE CAPACITY | CONTINUOUS INTRAVENOUS EPOPROSTENOL | Hypertension, Pulmonary - classification | Iloprost - administration & dosage | Iloprost - adverse effects | Humans | Middle Aged | Administration, Inhalation | Hypertension, Pulmonary - physiopathology | Male | Dyspnea - etiology | Exercise Tolerance - drug effects | Walking | Dyspnea - drug therapy | Female | Hemodynamics - drug effects | Hypertension, Pulmonary - drug therapy | Vasodilator Agents - adverse effects | Vasodilator Agents - administration & dosage | Drug therapy | Pulmonary hypertension | Hypertension | Pulmonary arteries | Nitric oxide | Mortality | Hemophilia
Journal Article
Statistics in Medicine, ISSN 0277-6715, 11/2008, Volume 27, Issue 26, pp. 5564 - 5564
‘Optimal phase I dose‐escalation trial designs in oncology—A simulation study’, by Oke Gerke and Harald Siedentop (Statistics in Medicine 2007, published...
Journal Article
Statistics in Medicine, ISSN 0277-6715, 11/2008, Volume 27, Issue 26, pp. 5564 - 5564
Journal Article
Statistics in Medicine, ISSN 0277-6715, 11/2008, Volume 27, Issue 26, p. 5564
Journal Article
Clinical Research in Cardiology, ISSN 1861-0684, 09/2016, Volume 105, Issue 9, p. 763
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1007/s00392-016-0986-9 Chronic...
Heart failure | Care and treatment | Cardiomyopathy | Analysis | Cardiac patients | Interferon beta | Clinical trials | Biological response modifiers | Cardiology | Health aspects | Heart diseases
Heart failure | Care and treatment | Cardiomyopathy | Analysis | Cardiac patients | Interferon beta | Clinical trials | Biological response modifiers | Cardiology | Health aspects | Heart diseases
Journal Article
Statistics in Medicine, ISSN 0277-6715, 11/2008, Volume 27, Issue 26, pp. 5329 - 5344
In phase I oncology trials conducted over the past few decades, the maximum tolerated dose (MTD) has usually been estimated by the traditional escalation rule...
clinical trial | dose finding | phase I | maximum tolerated dose | Bayesian ADEPT | oncology | Clinical trial | Oncology | Maximum tolerated dose | Phase I | Dose finding | MEDICINE, RESEARCH & EXPERIMENTAL | MEDICAL INFORMATICS | CONTINUAL REASSESSMENT METHOD | STATISTICS & PROBABILITY | CANCER | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | CLINICAL-TRIALS | MATHEMATICAL & COMPUTATIONAL BIOLOGY | Dose-Response Relationship, Drug | Medical Oncology - methods | Maximum Tolerated Dose | Antineoplastic Agents - adverse effects | Computer Simulation | Humans | Bayes Theorem | Clinical Trials, Phase I as Topic - methods | Antineoplastic Agents - administration & dosage | Models, Statistical | Research Design
clinical trial | dose finding | phase I | maximum tolerated dose | Bayesian ADEPT | oncology | Clinical trial | Oncology | Maximum tolerated dose | Phase I | Dose finding | MEDICINE, RESEARCH & EXPERIMENTAL | MEDICAL INFORMATICS | CONTINUAL REASSESSMENT METHOD | STATISTICS & PROBABILITY | CANCER | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | CLINICAL-TRIALS | MATHEMATICAL & COMPUTATIONAL BIOLOGY | Dose-Response Relationship, Drug | Medical Oncology - methods | Maximum Tolerated Dose | Antineoplastic Agents - adverse effects | Computer Simulation | Humans | Bayes Theorem | Clinical Trials, Phase I as Topic - methods | Antineoplastic Agents - administration & dosage | Models, Statistical | Research Design
Journal Article
Clinical Research in Cardiology, ISSN 1861-0684, 9/2016, Volume 105, Issue 9, pp. 763 - 773
Chronic viral infections of the heart are considered one antecedent event leading to progressive dysfunction of the myocardium, often with an impaired...
Chronic viral cardiomyopathy | Medicine & Public Health | Antiviral therapy, myocardial biopsies | Cardiology | Interferon beta | CARDIAC & CARDIOVASCULAR SYSTEMS | ENTEROVIRAL RNA | PERSISTENCE | VENTRICULAR ENDOMYOCARDIAL BIOPSY | MYOCARDITIS | B19 | DILATED CARDIOMYOPATHY | PREVALENCE | PATHOGENESIS | INFECTION | DYSFUNCTION | Adenoviridae Infections - drug therapy | Adenoviridae Infections - virology | Humans | Middle Aged | Male | Enterovirus Infections - physiopathology | Recovery of Function | Viral Load | Cardiomyopathies - physiopathology | Adenoviridae Infections - physiopathology | Enterovirus Infections - virology | Erythema Infectiosum - physiopathology | Time Factors | Cardiomyopathies - diagnosis | Erythema Infectiosum - diagnosis | Adult | Female | Erythema Infectiosum - virology | Cardiomyopathies - drug therapy | Enterovirus Infections - drug therapy | Enterovirus Infections - diagnosis | Double-Blind Method | Antiviral Agents - therapeutic use | Europe | Treatment Outcome | Erythema Infectiosum - drug therapy | Adenoviridae Infections - diagnosis | Interferon beta-1b - adverse effects | Cardiomyopathies - virology | Biopsy | Antiviral Agents - adverse effects | Interferon beta-1b - therapeutic use | Quality of Life | Aged | Chronic Disease
Chronic viral cardiomyopathy | Medicine & Public Health | Antiviral therapy, myocardial biopsies | Cardiology | Interferon beta | CARDIAC & CARDIOVASCULAR SYSTEMS | ENTEROVIRAL RNA | PERSISTENCE | VENTRICULAR ENDOMYOCARDIAL BIOPSY | MYOCARDITIS | B19 | DILATED CARDIOMYOPATHY | PREVALENCE | PATHOGENESIS | INFECTION | DYSFUNCTION | Adenoviridae Infections - drug therapy | Adenoviridae Infections - virology | Humans | Middle Aged | Male | Enterovirus Infections - physiopathology | Recovery of Function | Viral Load | Cardiomyopathies - physiopathology | Adenoviridae Infections - physiopathology | Enterovirus Infections - virology | Erythema Infectiosum - physiopathology | Time Factors | Cardiomyopathies - diagnosis | Erythema Infectiosum - diagnosis | Adult | Female | Erythema Infectiosum - virology | Cardiomyopathies - drug therapy | Enterovirus Infections - drug therapy | Enterovirus Infections - diagnosis | Double-Blind Method | Antiviral Agents - therapeutic use | Europe | Treatment Outcome | Erythema Infectiosum - drug therapy | Adenoviridae Infections - diagnosis | Interferon beta-1b - adverse effects | Cardiomyopathies - virology | Biopsy | Antiviral Agents - adverse effects | Interferon beta-1b - therapeutic use | Quality of Life | Aged | Chronic Disease
Journal Article
Statistics in Medicine, ISSN 0277-6715, 11/2008, Volume 27, Issue 26, pp. 5354 - 5355
Journal Article
Computational Statistics and Data Analysis, ISSN 0167-9473, 05/2012, Volume 56, Issue 5, pp. 1061 - 1068
Dose finding for classical hormonal contraceptives for women is usually done by investigating the surrogate endpoint inhibition of ovulation. For novel...
Pearl Index | Dose finding | Continual reassessment method | Contraception | Group-sequential design | 3+3 design | Dose de-escalation | DOWN DESIGNS | STATISTICS & PROBABILITY | I CLINICAL-TRIALS | LATE-ONSET TOXICITIES | CANCER | COMPUTER SCIENCE, INTERDISCIPLINARY APPLICATIONS | Group-sequential design Dose de-escalation Dose finding Contraception Pearl Index Continual reassessment method 3+3 design | Oral contraceptives | Contraceptives | Pregnancy | Design engineering | Ethics | Effectiveness | Light-emitting diodes | Statistics | Cancer
Pearl Index | Dose finding | Continual reassessment method | Contraception | Group-sequential design | 3+3 design | Dose de-escalation | DOWN DESIGNS | STATISTICS & PROBABILITY | I CLINICAL-TRIALS | LATE-ONSET TOXICITIES | CANCER | COMPUTER SCIENCE, INTERDISCIPLINARY APPLICATIONS | Group-sequential design Dose de-escalation Dose finding Contraception Pearl Index Continual reassessment method 3+3 design | Oral contraceptives | Contraceptives | Pregnancy | Design engineering | Ethics | Effectiveness | Light-emitting diodes | Statistics | Cancer
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 06/2013, Volume 31, Issue 18_suppl, pp. 4 - 4
4 Background: Sorafenib, an orally active inhibitor of VEGFR1-3 and Raf kinases, has shown promising clinical activity in single-arm phase II studies in...
Journal Article
American Journal of Therapeutics, ISSN 1075-2765, 01/2011, Volume 18, Issue 1, pp. 31 - 37
Arginine vasopressin (AVP) is increased in patients with heart failure (HF). Its actions are linked to free water reabsorption (V2-) and arteriolar...
heart failure | pharmacology | vasopressin | CONIVAPTAN | V-1A | TRIAL | ORAL TOLVAPTAN | DOGS | PHARMACOLOGY & PHARMACY | Arginine Vasopressin - antagonists & inhibitors | Cardiac Output - drug effects | Urodynamics - drug effects | Benzazepines - pharmacology | Cardiac Pacing, Artificial | Arginine Vasopressin - pharmacology | Pacemaker, Artificial | Heart Failure - drug therapy | Animals | Benzazepines - therapeutic use | Dogs | Vascular Resistance - drug effects | Blood Pressure - drug effects | Hemodynamics - drug effects | Antidiuretic Hormone Receptor Antagonists
heart failure | pharmacology | vasopressin | CONIVAPTAN | V-1A | TRIAL | ORAL TOLVAPTAN | DOGS | PHARMACOLOGY & PHARMACY | Arginine Vasopressin - antagonists & inhibitors | Cardiac Output - drug effects | Urodynamics - drug effects | Benzazepines - pharmacology | Cardiac Pacing, Artificial | Arginine Vasopressin - pharmacology | Pacemaker, Artificial | Heart Failure - drug therapy | Animals | Benzazepines - therapeutic use | Dogs | Vascular Resistance - drug effects | Blood Pressure - drug effects | Hemodynamics - drug effects | Antidiuretic Hormone Receptor Antagonists
Journal Article
American Journal of Roentgenology, ISSN 0361-803X, 06/2004, Volume 182, Issue 6, pp. 1399 - 1403
OBJECTIVE. The purpose of this study was to describe a largely observer-independent computer-assisted method for accurate quantitative analysis of bone marrow...
MRI | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Bone Marrow Diseases - diagnosis | Knee Joint | Humans | Magnetic Resonance Imaging - statistics & numerical data | Diagnosis, Computer-Assisted - statistics & numerical data | Observer Variation | Edema - diagnosis
MRI | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Bone Marrow Diseases - diagnosis | Knee Joint | Humans | Magnetic Resonance Imaging - statistics & numerical data | Diagnosis, Computer-Assisted - statistics & numerical data | Observer Variation | Edema - diagnosis
Journal Article
Clinical Journal of Sport Medicine, ISSN 1050-642X, 07/2008, Volume 18, Issue 4, pp. 358 - 362
OBJECTIVE:To investigate the outcome of subchondral stress fractures (SSF) of the knee after treatment with the prostacyclin analogue Iloprost or the opioid...
Knee | Bone marrow | Stress fractures | Iloprost | Magnetic resonance imaging | SPORT SCIENCES | magnetic resonance imaging | PHYSIOLOGY | ANALOG | stress fractures | SPONTANEOUS OSTEONECROSIS | bone marrow | knee | TIBIAL PLATEAU | BONE-MARROW EDEMA | FEMORAL CONDYLE | ORTHOPEDICS | Double-Blind Method | Vasodilator Agents - therapeutic use | Humans | Middle Aged | Knee Injuries - drug therapy | Analgesics, Opioid - therapeutic use | Male | Treatment Outcome | Tramadol - therapeutic use | Magnetic Resonance Imaging | Fracture Healing - drug effects | Knee Injuries - pathology | Fractures, Stress - pathology | Adult | Female | Iloprost - therapeutic use | Aged | Retrospective Studies | Drug Therapy, Combination | Fractures, Stress - drug therapy
Knee | Bone marrow | Stress fractures | Iloprost | Magnetic resonance imaging | SPORT SCIENCES | magnetic resonance imaging | PHYSIOLOGY | ANALOG | stress fractures | SPONTANEOUS OSTEONECROSIS | bone marrow | knee | TIBIAL PLATEAU | BONE-MARROW EDEMA | FEMORAL CONDYLE | ORTHOPEDICS | Double-Blind Method | Vasodilator Agents - therapeutic use | Humans | Middle Aged | Knee Injuries - drug therapy | Analgesics, Opioid - therapeutic use | Male | Treatment Outcome | Tramadol - therapeutic use | Magnetic Resonance Imaging | Fracture Healing - drug effects | Knee Injuries - pathology | Fractures, Stress - pathology | Adult | Female | Iloprost - therapeutic use | Aged | Retrospective Studies | Drug Therapy, Combination | Fractures, Stress - drug therapy
Journal Article
Medizinische Klinik, ISSN 0723-5003, 11/1999, Volume 94, Issue 11, pp. 603 - 608
Journal Article
Berlin, Techn. Universiẗat, Diss., 2008.
Dissertation
7/2008, Volume 66, Issue 4
Book Review
No results were found for your search.
Cannot display more than 1000 results, please narrow the terms of your search.